[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352482-105":59,"doc-detail-352482-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","subsequent-primary-neoplasms-and-mortality-among-survivors-of-childhood-cancer-in-alberta-canada","Subsequent Primary Neoplasms and Mortality Among Survivors of Childhood Cancer in Alberta, Canada","","Childhood cancer survivors face increased risk of chronic health conditions and death, yet fewer studies track how these risks evolve in contemporary cohorts. This retrospective, population-based cohort study followed 2,581 children diagnosed before age 18 in Alberta (2001–2018) through 31 December 2018, comparing subsequent primary neoplasms (SPNs) and mortality with the general population. Survivors experienced more SPNs and deaths, varying by initial cancer type and treatment, underscoring the need for long-term surveillance and tailored risk mitigation.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/subsequent-primary-neoplasms-and-mortality-among-survivors-of-childhood-cancer-in-alberta-canada/352482/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/subsequent-primary-neoplasms-and-mortality-among-survivors-of-childhood-cancer-in-alberta-canada/352482.png","ImageObject",300,407,{"name":92,"@type":93},"Rowan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the study design and population in Alberta?","Question",{"text":113,"@type":114},"The study used a retrospective, population-based cohort of individuals diagnosed with cancer before age 18 in Alberta, Canada, from 2001 to 2018, followed through 31 December 2018.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were subsequent primary neoplasms (SPNs) and mortality measured?",{"text":118,"@type":114},"Risks of SPNs and mortality were evaluated against the general Alberta population using standardized mortality and incidence ratios and absolute excess risks per 10,000 person-years, overall and after 5-year survival.",{"name":120,"@type":111,"acceptedAnswer":121},"What were the main findings regarding SPNs and deaths?",{"text":122,"@type":114},"Among 2,581 survivors, 50 individuals developed at least one SPN and 408 deaths occurred; excess mortality was much higher than expected, and excess deaths were predominantly due to recurrence/progression, with risks varying by treatment and cancer type.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},352482,1790536006,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":31,"preview_page_count":19,"preview_urls":145},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","Article  \nSubsequent Primary Neoplasms and Mortality Among Survivors of Childhood Cancer in Alberta, Canada  \nKing Wa Tam 1, Tona M. Pitt 1,2,3, Kathleen Reynolds 4,5, Maria Spavor 6,7, Tony H. Truong 1,8, Jennifer Giles 5, Gregory M. T. Guilcher 1,2,8, Natalie Logie 1, Iqra Rahamatullah 9, Fiona Schulte 1 and  \nMiranda M. Fidler-Benaoudia 1,3,9, *  \nAcademic Editor: Ronald de Krijger  \nReceived: 20 January 2026  \nRevised: 11 February 2026  \nAccepted: 12 February 2026  \nPublished: 20 February 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Oncology, University of Calgary, 2500 University Drive NW, Calgary, AB T2N 1N4, Canada; kingwa.tam@ucalgary.ca (K.W.T.); tpitt@ucalgary.ca (T.M.P.); [tony.truong@albertahealthservices.ca](tony.truong@albertahealthservices.ca) (T.H.T.); [greg.guilcher@albertahealthservices.ca](greg.guilcher@albertahealthservices.ca) (G.M.T.G.); [natalie.logie@albertahealthservices.ca](natalie.logie@albertahealthservices.ca) (N.L.);  \nfiona.schulte@ucalgary.ca (F.S.)  \n2 Department of Paediatrics, University of Calgary, 2500 University Drive NW, Calgary, AB T2N 1N4, Canada  \n3 Department of Cancer Epidemiology and Prevention Research, Cancer Care Alberta, Arthur Child Comprehensive Cancer Centre, 3395 Hospital Drive NW, Calgary, AB T2N 5G2, Canada  \n4 Department of Family Medicine, Cumming School of Medicine, University of Calgary, 2500 University Drive NW, Calgary, AB T2N 1N4, Canada; [kathya.reynolds@albertahealthservices.ca](kathya.reynolds@albertahealthservices.ca)  \n5 Long Term Survivors Clinic, Alberta Children’s Hospital, 28 Oki Drive NW, Calgary, AB T3B 6A8, Canada; [jennifer.giles@albertahealthservices.ca](jennifer.giles@albertahealthservices.ca)  \n6 Department of Paediatrics, University of Alberta, 11405-87 Avenue NW, Edmonton, AB T6G 1C9, Canada; [maria.spavor@albertahealthservices.ca](maria.spavor@albertahealthservices.ca)  \n7 Northern Alberta Childhood Cancer Survivor Program, 11135-84 Avenue NW, Edmonton, AB T6G 0V9, Canada  \n8 Haematology, Oncology, and Transplant Program, Alberta Children’s Hospital, 28 Oki Drive NW, Calgary, AB T3B 6A8, Canada  \n9 Department of Community Health Sciences, University of Calgary, 2500 University Drive NW, Calgary, AB T2N 1N4, Canada  \n* Correspondence: miranda.fidler-benaoudia@cancercarealberta.ca; Tel.: +1-587-231-4235  \nSimple Summary  \nChildren diagnosed with cancer face a higher risk of chronic health conditions and death both in the short term and long term. With improvements in treatment over the last 20 years, the risk of late effects and overall survival have changed, but there are relatively few studies examining how these risks changed over time. This study followed 2581 children diagnosed from 2001 to 2018 in Alberta, Canada, until 31 December 2018 . We identified those who developed a subsquent cancer and those who died during our follow-up and compared these rates to what was expected in the general population of Alberta. Children diagnosed with cancer experienced more subsequent cancers and deaths compared to the general population; these poor outcomes differed by initial cancer type and the treatment received, and highlight the need for long-term follow-up care for survivors of childhood cancer.  \nAbstract  \nBackground: While research shows childhood cancer survivors experience elevated subsequent primary neoplasm (SPN) and premature mortality risks, few studies have included contemporary survivors. Methods: This study quantifies the risk of SPNs and mortality among modern survivors of childhood cancer. Utilizing a retrospective, population-based cohort of individuals diagnosed with cancer before the age of 18 in Alberta, Canada (2001–2018), we evaluated their risks of SPNs and mortality compared to the general population in Alberta, overall and after 5-year survival, us","cbCaijmtbCtlZLjm","https://ap.wps.com/l/cbCaijmtbCtlZLjm","pdf",985933,"English","# Abstract\n## Background and Methods\n## Results\n## Conclusions","[{\"question\":\"What was the study design and population in Alberta?\",\"answer\":\"The study used a retrospective, population-based cohort of individuals diagnosed with cancer before age 18 in Alberta, Canada, from 2001 to 2018, followed through 31 December 2018.\"},{\"question\":\"How were subsequent primary neoplasms (SPNs) and mortality measured?\",\"answer\":\"Risks of SPNs and mortality were evaluated against the general Alberta population using standardized mortality and incidence ratios and absolute excess risks per 10,000 person-years, overall and after 5-year survival.\"},{\"question\":\"What were the main findings regarding SPNs and deaths?\",\"answer\":\"Among 2,581 survivors, 50 individuals developed at least one SPN and 408 deaths occurred; excess mortality was much higher than expected, and excess deaths were predominantly due to recurrence/progression, with risks varying by treatment and cancer type.\"}]","Subsequent Primary Neoplasms and Mortality Among Survivors of Childhood Cancer in Alberta, Canada | PDF",1790099866,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/608e3182642118f09e946eafec781461.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/55430d825aed542f2dbcf755e670cabb.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bd6a26173b44ea9c62d301ce0005389a.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d0b6fd2686ff8778be58e2696b39d776.webp",980,1385]